Carcinoma arising from endometrial tissue
Symptoms• Post menapusal bleeding
• Irregular perimenstrual bleeding
• Heavy irregualar bleeding
• Constitutional symptoms ( LOA, LOW, Anemic Sx)
• Blood stained vaginal discharge
Risk factors of Endometrica CA
- Age>50
- Family history/ previous breast Ca
- Historu of hereditary non polyposis colorectal ca ( life time risk 40-60%)
- Endometrial hyperplasia +atypia
- DM/HTN
- Unopposed action of estrogen
+ Early menarche
+ Nulliparous
+ Chronic anovoulatory cycles (PCOS/Obese)
+ Late menopause
+ Granulose cell ovarian tumor
- Exogenous
+ Hormone therapy (combined with progesterone reduces endm hyperplasia and ca
+ On tamoxifan
Physical Examination
Normal or bulky uterus
Investigations
• Blood Ix
CA125 (monitoring and recuurence)
FBC
LFT
RP
• TVS (endometrial thickness and morphology)
• Endometrial sampling (pippele sampling)
• Hysteroscopy
• Endometrial biopsy
• D&C /hysteroscopically
• CT (pelvis, abdomen, chest)
• Cystoscopy (tro bladder involvement)
Pathology
• ¾ arising from fundus
• 15% lower uterine cavity
Histological types
• Endometroid (75%)
• Adenoacanthoma
• Adenosquamous CA
• Papillary serous
• Clear cell
• Carcinosarcoma (malignant mixed mullerian turmor)
FIGO classification of endometrial Cancer
• Stage 1(confined to uterus)
1A- limited to endometrium
1B- invades less than half of myometrium
1C- invades more than half of myometrium
• Stage 2 (tumor invades cervix)
2A- endocervical glandular involvement
2B- cervical stromal invasion
• Stage3( local or regional spread)
3A- involve serosa
3B- vaginal involvement
3C- mets to pelvic and para aortic nodes
• Stage4 ( distant spread, bladder and rectal involvemnt)
Spread
• Direct (cervix, vagina, fallopian tube, ovary
• Lymphatic (pelvic, para aortic LN)
• Hematogenous (lung, liver) rare
Grading (based on deffrenciation and presence of mitotic figures
• G1- wel differentiated ,scanthy mit fig
• G2- moderately differentiated
• G3- poorly differentiated , presence of malignant cells
Management
• Stage1 : TAHBSO with peritoneal washing for cytology
• Stage2: werthin type redical hysterectomy with B/l pelvic lymphadenectomy +- para aortic dissection.
• Stage3: surgical debulking or radiotherapy to shrink the tumor
• Stage4: systemic chemo OR hormonal therapy.
Adjuvant therapies
• Radiotherapy : if >stage2,
• Hormone: for recurrence and for women not fit for surgey ( progesterone or tamoxifen)
Follow up
• Physical exam every 3-6 monthly for 2 years
• Vaginal cytology 6 monthly for 2 year
• CXR annually
• CA 125

